References
- Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. 2021 report.
- Ghidul ENSP pentru tratamentul dependen ei de tutun. European Network for Smoking and Tobacco Prevention. 2019.
- Ulmeanu R, Fildan AP, Oancea C, Mihăl an F. Recomandări de diagnostic și tratament în bronhopneumopatia obstructivă cronică. Editura Medicală, București. 2019. p 15-16.
- Bălă GP, Râjnoveanu RM, Tudorache E, et al. Air pollution exposure- the (in)visible risk factor for respiratory disease. Environ Sci Pollut Res Int. 2021; 28(16): 19615-19628.
- Negewo NA, Gibson PG, McDonald VM. COPD and its comorbidities: Impact, measurement and mechanisms. Respirology. 2015; 20(8):1160-71.
- Hlapcic I, Belamaric D, Bosnar M, et al. Combination of Systemic Inflammatory Biomarkers in Assessment of Chronic Obstructive Pulmonary Disease: Diagnostic Performance and Identification of Networks and Clusters. Diagnostics (Basel). 2020; 10(12): 1029.
- Wang Y, Xu J, Meng Y, Adcock IM, Yao X. Role of inflammatory cells in airway remodeling in COPD. Int J Chron Obstruct Pulmon Dis. 2018; 13:3341-3348.
- Chan SMH, Selemidis S, Bozinovski S, Vlahos R. Pathobiological mechanisms underlying metabolic syndrome (MetS) in chronic obstructive pulmonary disease (COPD): clinical significance and therapeutic strategies. Pharmacol Ther. 2019; 198:160-188.
- Córdoba-Lanús E, Baz-Dávila R, Espinoza-Jiménez A, et al. IL-8 gene variants are associated with lung function decline and multidimensional BODE index in COPD patients but not with disease susceptibility: a validation study. COPD. 2015; 12(1):55-61.
- Barnes PJ. Chronic obstructive pulmonary disease: effects beyond the lungs. PLoS Med. 2010; 7(3):e1000220.
- Che L, Yu C, Chen G, et al. The Inflammatory Response Induced by RELMβ Upregulates IL-8 and IL-1β Expression in Bronchial Epithelial Cells in COPD. Int J Chron Obstruct Pulmon Dis. 2021; 16:2503-2513.
- Oishi K, Matsunaga K, Shirai T, et al. Role of Type2 Inflammatory Biomarkers in Chronic Obstructive Pulmonary Disease. J Clin Med. 2020; 9(8):2670.
- De Llano LP, Cosío BG, Iglesias A, et al. Mixed Th2 and non-Th2 inflammatory pattern in the asthma-COPD overlap: a network approach. Int J Chron Obstruct Pulmon Dis. 2018; 13:591-601.
- Vogelmeier CF, Criner GJ, Martinez FJ, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 report. GOLD executive summary. Am J Respir Crit Care Med. 2017; 195(5):557–82.
- Perera WR, Hurst JR, Wilkinson TMA, et al. Inflammatory changes, recovery and recurrence at COPD exacerbation. Eur Respir J 2007; 29(3): 527–34.
- Perotin JM, Dury S, Renois F, et al. Detection of multiple viral and bacterial infections in acute exacerbation of chronic obstructive pulmonary disease: a pilot prospective study. J Med Virol. 2013; 85(5): 866–73.
- Ritchie AI, Wedzicha JA. Definition, Causes, Pathogenesis, and Consequences of Chronic Obstructive Pulmonary Disease Exacerbations. Clin Chest Med. 2020; 41(3):421-438.
- Bhowmik A, Seemungal TA, Sapsford RJ, Wedzicha JA. Relation of sputum inflammatory markers to symptoms and lung function changes in COPD exacerbations. Thorax. 2000; 55: 114–120.
- Rosales C. Neutrophil: A Cell with Many Roles in Inflammation or Several Cell Types. Front. Physiol. 2018; 9:113.
- Gan WQ, Man SF, Senthilselvan A, Sin DD. Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis. Thorax. 2004; 59(7):574-80.
- Katsiki N, Stoian AP, Steiropoulos P, et al. Metabolic Syndrome and Abnormal Peri-Organ or Intra-Organ Fat (APIFat) Deposition in Chronic Obstructive Pulmonary Disease: An Overview. Metabolites. 2020; 10(11):465.
- Miller J, Edwards LD, Agusti A, et al. Comorbidity, systemic inflammation and outcomes in the ECLIPSE cohort. Respir Med. 2013; 107: 1376–1384.
- Williams MC, Murchison JT, Edwards LD, et al. Coronary artery calcification is increased in patients with COPD and associated with increased morbidity and mortality. Thorax. 2014; 69: 718–723.
- Rabe KF, Hurst JR, Suissa S. Cardiovascular disease and COPD: dangerous liaisons? Eur Respir Rev. 2018; 27(149):180057.
- Zhou JS, Li ZY, Xu XC, et al. Cigarette smoke-initiated autoimmunity facilitates sensitisation to elastin-induced COPD-like pathologies in mice. Eur Respir J. 2020; 56(3):2000404.
- Andreeva E, Pokhasnikova M, Lebedev A, et al. Inflammatory parameters and pulmonary biomarkers in smokers with and without chronic obstructive pulmonary disease (COPD). J Thorac Dis. 2021; 13(8):4812-4829.
- Gao J, Zhan B. The effects of Ang-1, IL-8 and TGF-β1 on the pathogenesis of COPD. Mol Med Rep. 2012; 6(5):1155-9.
- Gea J, Pascual S, Casadevall C, et al. Muscle dysfunction in chronic obstructive pulmonary disease: update on causes and biological findings. J Thorac Dis. 2015; 7(10):E418-38.
- Crul T, Spruit MA, Gayan-Ramirez G, et al. Markers of inflammation and disuse in vastus lateralis of chronic obstructive pulmonary disease patients. Eur J Clin Invest. 2007; 37(11):897-904.
- Henrot P, Dupin I, Schilfarth P, et al. Main Pathogenic Mechanisms and Recent Advances in COPD Peripheral Skeletal Muscle Wasting. Int J Mol Sci. 2023; 24(7):6454.
- Akpınar EE, Akpınar S, Ertek S, et al. Systemic inflammation and metabolic syndrome in stable COPD patients. Tuberk Toraks. 2012; 60(3):230-7.
- Minas M, Kostikas K, Papaioannou AI, et al. The association of metabolic syndrome with adipose tissue hormones and insulin resistance in patients with COPD without co-morbidities. COPD. 2011; 8(6):414-20.
- Sun K, Kusminski CM, Scherer PE. Adipose tissue remodeling and obesity. J Clin Invest. 2011; 121(6):2094-101.
- Watz H, Waschki B, Kirsten A, et al. The metabolic syndrome in patients with chronic bronchitis and COPD: frequency and associated consequences for systemic inflammation and physical inactivity. Chest. 2009; 136(4):1039-1046.
- Passey SL, Hansen MJ, Bozinovski S, et al. Emerging therapies for the treatment of skeletal muscle wasting in chronic obstructive pulmonary disease. Pharmacol Ther. 2016; 166:56-70.
- Trøseid M, Lappegård KT, Claudi T, et al. Exercise reduces plasma levels of the chemokines MCP-1 and IL-8 in subjects with the metabolic syndrome. Eur Heart J. 2004; 25(4):349-55.
- De Luca C, Olefsky JM. Inflammation and insulin resistance. FEBS Lett. 2008; 582(1):97-105.
- Gerhardt CC, Romero IA, Cancello R et al. Chemokines control fat accumulation and leptin secretion by cultured human adipocytes. Mol Cell Endocrinol. 2001; 175:81–92.
- Sarir H, Mortaz E, Karimi K, et al. Cigarette smoke regulates the expression of TLR4 and IL-8 production by human macrophages. J Inflamm (Lond). 2009; 6:12.
- Kotlyarov S. High-Density Lipoproteins: A Role in Inflammation in COPD. Int J Mol Sci. 2022; 23(15):8128.